Part ofHealthcare →

The civic record

Read. Follow. Verify.

HB 915OHIOSession 136State Billin committee

High Impact

Ohio Bill HB 915 Requires Health Plans and Medicaid to Cover Epinephrine and Glucagon for Minors with Cost-Sharing Caps

Original title: Require health plans, Medicaid to cover epinephrine and glucagon

Last action · May 20, 2026: Referred to InsuranceSponsors: Phillip M. Robinson, Jr. and 14 others

Bill progressHistory & official text ↓

Introduced

Committee

Floor Vote

Passed

Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Would Do

Ohio House Bill 915 requires private health benefit plans and the state Medicaid program to cover medically necessary epinephrine and glucagon in any prescribed form for individuals aged 18 and younger, while capping at $60 per package of two autoinjectors or equivalent dose.

Why it matters

Families of children and teenagers with severe allergies or diabetes face lower out-of-pocket prescription expenses and guaranteed insurance coverage for essential emergency medications.

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

Individuals 18 years of age and younger

Minors requiring epinephrine or glucagon receive guaranteed health plan and Medicaid coverage with capped out-of-pocket costs.

Directly affected

Health plan issuers

Health benefit plans must update coverage rules to include epinephrine and glucagon for minors and enforce statutory cost-sharing caps.

Directly affected

Department of Medicaid

The department must ensure Medicaid programs cover prescribed epinephrine and glucagon for minors without exceeding permitted cost-sharing limits.

Directly affected

Medicaid providers

Providers are subject to strict rules prohibiting the waiver of recipient copayments or paying copayments on behalf of recipients.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Who is eligible for the epinephrine and glucagon coverage mandate under this bill?

Covered persons and Medicaid enrollees who are eighteen years of age or younger.

What is the maximum cost-sharing amount allowed for epinephrine or glucagon autoinjectors?

Sixty dollars per package containing two autoinjectors, or sixty dollars per dose equivalent to the dose contained within two autoinjectors for other prescribed forms.

Can a Medicaid provider pay a recipient's required copayment?

No, providers, drug manufacturers, and their representatives, employees, or agents are explicitly prohibited from paying any copayment on behalf of a Medicaid recipient.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Follow the record

Votes, people, money & the original source

Where This Stands

Currently in committee. The next step in the legislative lifecycle is Floor Vote.

Procedural history

2 actions

May 20, 2026HouseCommittee
Referred to Insurance
May 19, 2026HouseIntroduced
Introduced

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →